Clinical Trials Directory

Trials / Completed

CompletedNCT04173377

Elbow Outcomes Clinical Study (WELBOW)

Status
Completed
Phase
Study type
Observational
Enrollment
310 (actual)
Sponsor
Stryker Trauma and Extremities · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

WELBOW study is an international, ambispective and prospective, single arm, multicenter, observational, non-comparative, Post-Market Clinical Follow-up (PMCF).

Detailed description

WELBOW study is an international, ambispective and prospective, single arm, multicenter, observational, non-comparative, Post-Market Clinical Follow-up (PMCF). Outcome data collected from this study will provide the basis for Post-Market Surveillance (PMS) reporting, Clinical Study Report (CSR) and Clinical Evaluation Report (CER) on Elbow system devices and support peer-reviewed publications on long-term product performance and safety.

Conditions

Timeline

Start date
2020-06-08
Primary completion
2024-09-17
Completion
2024-09-17
First posted
2019-11-21
Last updated
2025-09-16

Locations

7 sites across 4 countries: Belgium, Canada, France, United Kingdom

Source: ClinicalTrials.gov record NCT04173377. Inclusion in this directory is not an endorsement.

Elbow Outcomes Clinical Study (WELBOW) (NCT04173377) · Clinical Trials Directory